Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty.
Of 50 patients surviving 2 years or longer after HLA-identical sibling bone marrow transplantation for haematological malignancy or severe aplastic anaemia, five developed avascular necrosis of the femoral head. All had previously received corticosteroid therapy post-transplant for graft-versus-host disease. Median day of onset of symptoms was 545 days post-transplant (range 249-731). Clinical, radiological and radionuclide findings were typical of osteonecrosis. One patient has had bilateral hemiarthroplasties and one total hip replacements performed, both with excellent results. Bilateral arthroplasties are planned for a third patient but, interestingly, the disease process in the other two patients has been relatively mild with no progression over a period of greater than 256 and greater than 825 days, respectively. Since one patient had as little as 14 days treatment with prednisone, this complication should be borne in mind when designing prophylactic regimens for minimisation of GVHD that include corticosteroids.
Atkinson
K
K
Department of Haematology, St Vincent's Hospital, Sydney, Australia.
Cohen
M
M
Biggs
J
J
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D005271:Femur Head Necrosis / Q000209:etiology / Q000601:surgery*; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000209:etiology; D006622:Hip Prosthesis; D006801:Humans
D000305:Adrenal Cortex Hormones